
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RCUS · as of Jun 8, 2026
Key Statistics
Explore Arcus Biosciences, Inc. Data
rcus stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 83.3%
The RCUS analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $31.17, representing +33.66% upside from the current price of $23.32.
Competitors & Peers
rcus competitorsStock Performance
Full HistoryAbout Arcus Biosciences, Inc.
Arcus Biosciences, Inc. is a U.S.-based, clinical-stage biopharmaceutical company dedicated to discovering and commercializing innovative cancer therapies. Its pipeline features several promising drug…
what is arcus biosciences, inc. · rcus stock overview · arcus biosciences, inc. company profile · who is arcus biosciences, inc. ceo · rcus NYSE · arcus biosciences, inc. headquarters · arcus biosciences, inc. business segments
About Stock Overview & Key Data
Arcus Biosciences, Inc. (RCUS) is a Healthcare company in the Biotechnology industry, listed on NYSE since Mar 15, 2018. As of the latest trading session, RCUS stock price is $23.32, with a market capitalization of $2.3B. The stock has returned +136.75% over the past 12 months and -2.14% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Arcus Biosciences, Inc. stock is Buy, with an average 12-month price target of $31.17. In fiscal year 2025, Arcus Biosciences, Inc. reported revenue of $247.0M and net income of -$353.0M. For detailed data — including Arcus Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arcus Biosciences, Inc. (RCUS) stock price is $23.32. The stock is traded on NYSE under the ticker symbol RCUS. The 52-week range is $7.91 – $28.72.